Combinación de etinilestradiol/dienogest en la anticoncepción oral

E F Pérez-Campos
2016 · doi:10.21840/siic/141802 · W2810260798
report OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-27 · read from full text ⓘ

This expert interview discusses the combination of ethinylestradiol and dienogest as an oral contraceptive option, highlighting its classification as a progestin-based therapy. The text reviews the pharmacological properties and clinical application of this specific hormonal formulation within gynecological practice. It serves as an informational overview for healthcare providers regarding the use of dienogest in birth control regimens. Relevance to endometriosis: dienogest is widely used off-label or approved for treating endometriosis-associated pain, though this paper focuses primarily on its role in contraception.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Las formulaciones de los anticonceptivos orales (AO) han variado a lo largo de más de 50 años. A partir de estudios de farmacovigilancia y de post comercialización, se observó que el AO compuesto por 30 µg de etinilestradiol y 2 mg de dienogest se comportó como un anticonceptivo eficaz, seguro y bien tolerado.
Full text 774 characters · extracted from oa-doi-fallback · click to expand
Jefe de Servicio de Obstetricia y Ginecología, Hospital General Requena,Valencia, España Palabras clave anticonceptivos orales, dienogest, gestágeno anticonceptivos orales, dienogest, gestágeno Key Words oral contraceptives, dienogest, gestagen oral contraceptives, dienogest, gestagen Especialidades Clasificación en siicsalud Entrevista> Expertos de Iberoamérica> Entrevista completa Exclusivo para suscriptores assinantes Imprimir nota Extensión de la entrevista: +/- 2.58 páginas impresas en papel A4 Clasificación en siicsalud Entrevista> Expertos de Iberoamérica> Entrevista completa Exclusivo para suscriptores assinantes Imprimir nota Extensión de la entrevista: +/- 2.58 páginas impresas en papel A4 ua40317 Copyright siicsalud © 1997-2026 ISSN siicsalud: 1667-9008

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-11T06:10:27.824888+00:00
License: CC0 · commercial use OK